CVRX CVRx Inc.: Net earnings per share growth forecast for next year

CVRx (CVRX) - corporate logo

CVRx, Inc. (CVRX) develops neurostimulators while facing costly marketing campaigns and insurance coverage risks. The engineering team is advancing innovative neuromodulation by attracting medtech experts. Despite its reliance on a single product, the company maintains global leadership. The forward-looking net income per share growth forecast demonstrates analyst expectations, where 7.70 reflects the latest metric value.

CVRX: CVRx Inc Expected earnings per share growth for next year 07/04/2022 - 11/11/2026

Analytical breakdowns for CVRx, Inc.

- share price and consensus valuation forecast:
Stock Price CVRx, Inc|CVRX - Analyst Median Target
- company stock capitalization data:
Market Value CVRx, Inc.|CVRX - Business Value
- company book value details:
Book Value per Share CVRx, Inc.|CVRX - Company Net Assets|Market Cap to Net Assets Ratio cvrx.com|CVRX - Company Total Asset Base
- debt obligations and liquidity statistics:
Total Debt to Capital CVRx, Inc.|CVRX - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio CVRx|CVRX - Company Debts|Debt to Book Capitalization Ratio CVRx, Inc.|CVRX - Company Long-Term Loans and Borrowings|Company Current Liabilities CVRx, Inc.|Quick Ratio cvrx.com
- earnings and valuation multiples information:
CVRX - Final Profit|Projected Future Earnings CVRx, Inc.|CVRX - Market Cap to Earnings|Forward P/E Multiple CVRx, Inc.|CVRX - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CVRx, Inc.|CVRX - Income before deduction of interest, taxes and amortization|Net earnings per share for the last 12 months CVRx, Inc.|CVRX - Earnings per share for the last four quarters|Quarterly EPS earnings growth cvrx.com|CVRX - Net earnings per share growth this year|Expected earnings per share growth for next year CVRx, Inc.
Summary company analysis:CVRX, CVRx, Inc
Finished products of CVRx Inc.

This indicator reflects the expected growth rate of net income, determining the asset's investment attractiveness through the lens of future earnings. Analyzing the projected earnings per share (EPS) dynamics allows for the identification of trend reversal points or phases of capital stagnation. The metric is calculated as the percentage deviation of the forecasted EPS from its current value. For CVRx, Inc. (CVRX), this growth is driven by scaling the sales force for stimulation systems without the acquisition of external assets.

Competitor analysis for CVRx, Inc.

REGN (Regeneron Inc.) - Earnings growth forecast for next year|iRhythm Corp (IRTC) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Lantheus Holdings, Inc. (LNTH)|mineralystx.com - Projected earnings per share growth rate for next year|Earnings growth forecast for next year HTFL (HeartFlow Inc)|KMTS - Expected earnings per share growth for next year|ESPR: Expected earnings per share growth for next year|Consensus forecast of earnings per share growth for next year Amarin Pharma AMRN|AVR: Earnings growth forecast for next year|Expected earnings per share growth for next year Tenaya Therapeutics, Inc.|Expected earnings per share growth for next year MIST|Net earnings per share growth forecast for next year CRDL|Net earnings per share growth forecast for next year HeartBeam Corp (BEAT)|TENX (Tenax Therapeutics Inc) - Expected earnings per share trend next year|Adagio Medical Holdings - Expected earnings per share growth for next year|BCDA: Projected earnings per share growth rate for next year|Catheter Precision, Inc. - Earnings growth forecast for next year|Expected earnings per share trend next year ABIO (ARCA Biopharma)|ACST: Earnings growth forecast for next year|Expected net earnings per share growth next year Aerovate Therapeutics, Inc (AVTE)|VERV (Verve Therapeutics Inc.) - Earnings growth forecast for next year|Earnings growth forecast for next year Windtree